# US 2022/0032046 A1 · Tissue-stimulating prosthesis dissolution barrier

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0032046 A1
- Document ID: US20220032046A1
- Status: Published application
- Kind: A1
- Application number: 17/413,712
- Filed: 2020-06-10
- Published: 2022-02-03
- Earliest claimed: 2019-06-13
- Assignees: Cochlear Limited
- Applicants: Cochlear Limited
- Inventors: Paul Michael Carter
- Web page: https://patentgrep.com/patent/US20220032046A1

## CPC

- A61L 27/04: Metals or alloys
- A61N 1/0541: {Cochlear electrodes}
- A61L 27/34: Macromolecular materials
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 31/022: {Metals or alloys}
- A61L 31/10: Macromolecular materials
- A61L 31/145: {Hydrogels or hydrocolloids}
- A61N 1/36038: {Cochlear stimulation}
- A61L 2430/14: for ear reconstruction or ear implants, e.g. implantable hearing aids
- A61N 1/0551: {Spinal or peripheral nerve electrodes}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Presented herein are dissolution barriers for use with tissue-stimulating prostheses. As described further below, a tissue-stimulating prosthesis comprises a stimulating assembly including an elongate insulating carrier member and a plurality of electrode contacts disposed along the carrier member. A continuous dissolution barrier is disposed on the surface of the stimulating assembly so as to substantially encapsulate/enclose the plurality of electrode contacts and the carrier member. The continuous dissolution barrier is configured to inhibit in situ dissolution of the plurality of electrode contacts.

## Claims

### Claim 1

A tissue-stimulating prosthesis, comprising:
a stimulating assembly comprising an elongate carrier member and a plurality of spaced electrode contacts disposed along the elongate carrier member configured to at least one of source or sink current signals; and
a dissolution barrier encapsulating the stimulating assembly, wherein the dissolution barrier is configured to inhibit in situ dissolution of the plurality of electrode contacts.

### Claim 2 (depends on 1)

The tissue-stimulating prosthesis of claim 1, wherein the dissolution barrier is configured to permit conduction of electrical current, but inhibit movement of metal ions from a surface of the plurality of electrode contacts.

### Claim 3 (depends on 1)

The tissue-stimulating prosthesis of claim 1, wherein the dissolution barrier has a conductivity, and wherein the conductivity is greater than a first threshold and lower than a second threshold.

### Claim 4 (depends on 3)

The tissue-stimulating prosthesis of claim 3, wherein the first and second thresholds are selected based on a surface area of the plurality of electrode contacts and a thickness of the dissolution barrier.

### Claim 5 (depends on 3)

The tissue-stimulating prosthesis of claim 3, wherein the stimulating assembly is configured to be implanted in a recipient in a location in which the dissolution barrier is in contact with a body fluid of the recipient, and wherein the second threshold is approximately the same as the conductivity of the body fluid.

### Claim 6 (depends on 3)

The tissue-stimulating prosthesis of claim 3, wherein the stimulating assembly is configured to be implanted in a recipient in a location in which the dissolution barrier is in contact with a body fluid of the recipient, and wherein the second threshold is less than the conductivity of the body fluid.

### Claim 7 (depends on 6)

The tissue-stimulating prosthesis of claim 6, wherein the stimulating assembly is configured to be implanted in a recipient's cochlea such that the dissolution barrier is in contact with perilymph of the recipient, and wherein the second threshold is approximately 180 Siemens per meter (Sm−1).

### Claim 8 (depends on 3)

The tissue-stimulating prosthesis of claim 3, wherein the first threshold is a level at which an impedance of the dissolution barrier is less than 10% of a total impedance of each of the plurality of electrode contacts.

### Claim 9 (depends on 3)

The tissue-stimulating prosthesis of claim 3, wherein the first threshold is approximately 1 Kiloohm (kΩ).

### Claim 10 (depends on 3)

The tissue-stimulating prosthesis of claim 3, wherein the first threshold is a minimum conductivity (Cmin) given in Siemens per meter, and wherein:
Cmin=T/1.5·10−4,
wherein T is the barrier material thickness in meters.

### Claim 11 (depends on 1)

The tissue-stimulating prosthesis of claim 1, wherein the dissolution barrier comprises at least one of a biocompatible conducting polymer or a biocompatible conducting hydrogel.

### Claim 12 (depends on 1)

The tissue-stimulating prosthesis of claim 1, wherein the dissolution barrier comprises dissolution resistant nanoparticles suspended in at least an insulating solid.

### Claim 13 (depends on 1)

The tissue-stimulating prosthesis of claim 1, wherein the dissolution barrier comprises at least one of a biocompatible woven insulating polymer or plastic.

### Claim 14 (depends on 1)

The tissue-stimulating prosthesis of claim 1, wherein the dissolution barrier comprises a self-assembled monolayer.

### Claim 15 (depends on 1)

The tissue-stimulating prosthesis of claim 1, wherein the dissolution barrier comprises an ion permeable membrane configured to selectively allow movement of conducting ions through drift while blocking diffusion of metal ions.

### Claim 16 (depends on 15)

The tissue-stimulating prosthesis of claim 15, wherein the ion permeable membrane is configured to selectively allow movement of conducting ions through drift while blocking diffusion of metal ions based on at least one of a size of the ions, a valency of the ions, or a frequency of movement of the ions.

### Claim 17 (depends on 1)

The tissue-stimulating prosthesis of claim 1, wherein the plurality of electrode contacts are thin-film electrode contacts.

### Claim 18

An apparatus, comprising:
an implantable carrier member formed from an insulating material and having a center longitudinal axis and an outer surface;
a plurality of electrode contacts distributed on the outer surface of the carrier member along the longitudinal axis for applying electrical stimulation signals to adjacent neural tissue; and
a continuous dissolution barrier layered on each of the plurality of electrode contacts and the carrier member.

### Claim 19 (depends on 18)

The apparatus of claim 18, wherein the plurality of electrode contacts are each spaced from one another by sections of the carrier member, and wherein the continuous dissolution barrier is layered on the plurality of electrode contacts and the sections of the carrier member between the plurality of electrode contacts.

### Claim 20 (depends on 18)

The apparatus of claim 18, wherein the dissolution barrier is configured to permit conduction of electrical current, but inhibit movement of metal ions from the surface of the plurality of electrode contacts.

### Claim 21 (depends on 18)

The apparatus of claim 18, wherein the dissolution barrier has a conductivity, and wherein the conductivity is greater than a first threshold and lower than a second threshold.

### Claim 22 (depends on 21)

The apparatus of claim 21, wherein the first and second thresholds are selected based on a surface area of the plurality of electrode contacts and a thickness of the dissolution barrier.

### Claim 23 (depends on 21)

The apparatus of claim 21, wherein the apparatus is configured to be at least partially implanted in a recipient in a location in which the dissolution barrier is in contact with a body fluid of the recipient, and wherein the second threshold is approximately the same as the conductivity of the body fluid.

### Claim 24 (depends on 21)

The apparatus of claim 21, wherein the apparatus is configured to be at least partially implanted in a recipient in a location in which the dissolution barrier is in contact with a body fluid of the recipient, and wherein the second threshold is less than the conductivity of the body fluid.

### Claim 25

(canceled)

### Claim 26

(canceled)

### Claim 27

(canceled)

### Claim 28

(canceled)

### Claim 29

(canceled)

### Claim 30

(canceled)

### Claim 31

(canceled)

### Claim 32

(canceled)

### Claim 33 (depends on 18)

The apparatus of claim 18, wherein the dissolution barrier comprises an ion permeable membrane configured to selectively allow movement of conducting ions through drift while blocking diffusion of metal ions.

### Claim 34 (depends on 33)

The apparatus of claim 33, wherein the ion permeable membrane is configured to selectively allow movement of conducting ions through drift while blocking diffusion of metal ions based on at least one of a size of the ions, a valency of the ions, or a frequency of movement of the ions.

### Claim 35

(canceled)

### Claim 36

A method, comprising:
providing a plurality of electrode contacts arranged in an elongate array;
encapsulating the plurality of electrode contacts in implantable carrier member formed from an insulating material, wherein the plurality of electrode contacts extend along a longitudinal axis of the carrier member and are positioned at an outer surface of the carrier member;
exposing a surface of the each of the plurality of electrode contacts for use in applying electrical stimulation signals to adjacent neural tissue; and
layering a continuous dissolution barrier on each of the plurality of electrode contacts and the carrier member.

### Claim 37 (depends on 36)

The method of claim 36, wherein layering a continuous dissolution barrier on each of the plurality of electrode contacts and the carrier member comprises:
dip coating the carrier member with electrode contacts.

### Claim 38 (depends on 36)

The method of claim 36, wherein layering a continuous dissolution barrier on each of the plurality of electrode contacts and the carrier member comprises:
spraying the continuous dissolution barrier onto each of the plurality of electrode contacts and the carrier member.

### Claim 39 (depends on 36)

The method of claim 36, wherein the continuous dissolution barrier has a conductivity, and wherein the conductivity is greater than a first threshold and lower than a second threshold.

### Claim 40

(canceled)

### Claim 41

(canceled)
